Obese individuals with type 2 diabetes should perform resistance exercises after dinner
the ONA take:
According to a new study published in the Journal of Applied Physiology, researchers from the University of Missouri Department of Nutrition and Exercise Physiology have found that individuals with type 2 diabetes can decrease their risk of cardiovascular diseases more effectively by exercising after dinner.
For the study, researchers studied the effects of resistance exercises, such as abdominal crunches, leg curls, and seated calf raises in obese individuals with type 2 diabetes. During one visit, participants exercised for 45 minutes before eating dinner and after dinner during another visit.
Results showed that participants who exercised before dinner were only able to reduce the blood sugar levels, but participants who exercised after dinner were able to reduce both fat and sugar levels. This research may provide insight for those who exercise every day but are not experiencing any weight loss benefit.
The researchers also found that blood sugar and fat level improvements did not extend into the next day, suggesting that individuals need to practice daily resistance exercise after to dinner to maintain these improvements.
Individuals with type 2 diabetes can decrease their risk of cardiovascular diseases more effectively by exercising after dinner.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|